In a special feature for Pharma Times, Harry Malcolm, Principal Consultant at Rubica, delves into the world of mergers and acquisitions (M&A) and candidly:
- Discusses the common challenges leading to the frequent failure of M&A endeavors in pharma,
- Sheds light on the often overlooked “people aspect” of M&As and the far-reaching implications it can have,
- Offers insights from senior pharma leaders at AstraZeneca, CSL Vifor, and Sobi on the essential components for effectively integrating people in an M&A process
- Shares practical ideas on how to ensure the ‘people aspect’ of an M&A isn’t neglected
You can take a read of the full article by clicking here.